Fri Sep 20 12:44:04 UTC 2024: ## Autonomix Medical to Showcase Precision Nerve-Targeting Technology at Octane Medical Innovation Forum

**THE WOODLANDS, TX – September 20, 2024** – Autonomix Medical, Inc. (NASDAQ: AMIX), a medical device company pioneering innovative nerve-targeted treatments, announced today its selection for a featured podium presentation at the upcoming Octane Medical Innovation Forum. The event, scheduled for October 8-9 in Irvine, California, will bring together leading industry experts, entrepreneurs, investors, and thought leaders to discuss the latest advancements in medical technology.

At the forum, Autonomix CEO Brad Hauser will present the company’s cutting-edge minimally invasive nerve-sensing, ablation, and verification platform. This technology boasts the potential to revolutionize treatment for various conditions, including chronic pain management, hypertension, and cardiology.

The key feature of Autonomix’s platform is a catheter-based microchip sensing array antenna, capable of detecting and differentiating neural signals with 3,000 times greater sensitivity than current technologies. This remarkable sensitivity allows for precise identification of target nerves, followed by targeted ablation using the company’s proprietary radio frequency (RF) technology.

This innovative approach enables a “sense, treat, and verify” methodology for addressing a wide range of diseases, offering a more precise and potentially safer alternative to traditional methods like opioid therapy or invasive ethanol injections.

Autonomix is initially focusing its research on pain management, particularly pancreatic cancer, a condition currently lacking reliable solutions. The company believes its platform technology holds the potential to address dozens of indications across various disease spectra, including cardiology, hypertension, and chronic pain management.

While still under investigation and not yet cleared for marketing in the United States, Autonomix’s innovative technology promises a significant advancement in the field of medical treatment, potentially improving patient outcomes and revolutionizing how diseases involving the nervous system are managed.

Read More